Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Charlie Hospital Semarang TbkISX:RSCH +9.88%24 5-Year Yield-on-Cost % is 0.00 as of Sep. 03, 2026. GuruFocus rates ISX:RSCH with a GF Score™ of 24/100. The stock has 1 warning sign investors should review. Among 280 Healthcare Providers & Services companies, PT Charlie Hospital Semarang Tbk ranks worse than 357142.5% on this metric.
The historical rank and industry rank for PT Charlie Hospital Semarang Tbk's 5-Year Yield-on-Cost % or its related term are showing as below:
ISX:RSCH's 5-Year Yield-on-Cost % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.98 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
PT Charlie Hospital Semarang Tbk (ISX:RSCH) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
PT Charlie Hospital Semarang Tbk 5-Year Yield-on-Cost % Related Terms
ISX:RSCH vs HCA, THC, EHC: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, PT Charlie Hospital Semarang Tbk's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Charlie Hospital Semarang Tbk 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Charlie Hospital Semarang Tbk's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where PT Charlie Hospital Semarang Tbk's 5-Year Yield-on-Cost % falls into.
PT Charlie Hospital Semarang Tbk 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
PT Charlie Hospital Semarang Tbk (ISX:RSCH) has a 5-Year Yield-on-Cost % of 0.00 as of Sep. 03, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on PT Charlie Hospital Semarang Tbk and its competitors. According to the industry distribution chart, PT Charlie Hospital Semarang Tbk ranks #999999 out of 280 companies in the Healthcare Providers & Services industry.
Is PT Charlie Hospital Semarang Tbk's 5-Year Yield-on-Cost % too high?
PT Charlie Hospital Semarang Tbk's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, PT Charlie Hospital Semarang Tbk ranks #999999 out of 280 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, PT Charlie Hospital Semarang Tbk has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does PT Charlie Hospital Semarang Tbk's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Charlie Hospital Semarang Tbk ranks #999999 out of 280 companies for 5-Year Yield-on-Cost %. This places PT Charlie Hospital Semarang Tbk in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.98. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.98, based on 280 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on PT Charlie Hospital Semarang Tbk and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Charlie Hospital Semarang Tbk's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Charlie Hospital Semarang Tbk stock overvalued right now?
PT Charlie Hospital Semarang Tbk (ISX:RSCH) has a current 5-Year Yield-on-Cost % of 0.00. The current 5-Year Yield-on-Cost % is 0.00. PT Charlie Hospital Semarang Tbk's overall GF Score™ is 24/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For PT Charlie Hospital Semarang Tbk (ISX:RSCH), the current 5-Year Yield-on-Cost % is 0.00 as of Sep. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PT Charlie Hospital Semarang Tbk is engaged in private hospital activities with type D hospital qualifications located in Kendal Regency. It provides medical facilities, such as a 24-hour emergency room, Specialist Polyclinic services, Central Surgical Installation, Intensive Care Unit (ICU), Perina, Laboratory, Radiology, Pharmacy, and other supporting facilities. It operates in three segments, namely Hospital service consist of medical goods and services provided to out patients and inpatients. Construction materials trading and Construction activities include services rendered on a fee or contract basis, as well as the construction, maintenance, or reconstruction of residential, office, industrial, commercial, healthcare, educational, lodging, entertainment/sports, and other buildings.
24GF Score
Get the complete analysis for ISX:RSCH
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:RSCH has been successfully added to your 
